scholarly journals Cutaneous Mucormycosis Resulting from Hematogenous Dissemination of Rhizomucor pusillus in an Immunocompromised Patient

2020 ◽  
pp. 275-278
Author(s):  
Sébastien Menzinger ◽  
Sabah Sid’Amar ◽  
Gürkan Kaya
2011 ◽  
Vol 37 (4) ◽  
pp. 355-357 ◽  
Author(s):  
E. Hadaschik ◽  
R. Koschny ◽  
B. Willinger ◽  
P. Hallscheidt ◽  
A. Enk ◽  
...  

2006 ◽  
Vol 6 (8) ◽  
pp. 536 ◽  
Author(s):  
BC Becker ◽  
FR Schuster ◽  
B Ganster ◽  
HP Seidl ◽  
I Schmid

2020 ◽  
Vol 12 (3) ◽  
pp. 168-173 ◽  
Author(s):  
Victoria S. Humphrey ◽  
Xiaoxiao Li ◽  
Sonal Choudhary ◽  
Timothy Patton

Disseminated mucormycosis is a rare, opportunistic, and aggressive infection typically presenting in immunocompromised patients. Herein, we report a 55-year-old male with a past medical history of Philadelphia-negative B-cell acute lymphoblastic leukemia who presented with a 2-month history of non-painful necrotic ulcers on the nose, knuckles, elbow, foot, and scrotum following 3 months of voriconazole (VRC) exposure in the setting of an unrelated fungal pneumonia. Our case reinforces the virulent and often fatal nature of the disease amongst immunocompromised patients, along with extensive VRC exposure as a possible supplementary risk factor. Disseminated cutaneous mucormycosis should be regarded as a differential diagnosis in all immunocompromised patients, especially those with hematologic malignancies or a history of VRC use, who present with cutaneous ulcerations and eschars.


2017 ◽  
Vol 2017 (3) ◽  
Author(s):  
Arul E. Suthananthan ◽  
Sharnice A. Koek ◽  
Kishore Sieunarine

2020 ◽  
Author(s):  
Mauricio Portillo ◽  
Shyam Allamaneni ◽  
Richard Goodman

UNSTRUCTURED Cunninghamella species are an extremely rare cause of fungal infections. The usual mode of transmission is through inhalation however rare cases of cutaneous spread have been reported. The objective of this clinical case report is to highlight the uniqueness of which the patient acquired the infection, the progression, and control of it. A 57-year-old male with chronic lymphocytic leukemia was found to have an abscess next to his peripherally inserted central catheter (PICC) line. The abscess culture grew back Cunninghamella and was debrided and treated with a novel antifungal. The fungal infection was controlled and the total timeframe took 28 days. Rapid recognition and prompt treatment demonstrate the prevention of rapidly progressive angioinvasian and further systemic complications. This case also proves that a novel antifungal may be appropriate in controlling the spread of Cunninghamella species.


Sign in / Sign up

Export Citation Format

Share Document